Stevens Lindsey - Cancer Research UK and UCL Cancer Trials Centre, University College London

基本信息

浏览量：75

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Quality of Life in Advanced-Stage, Asymptomatic, Non-Bulky Follicular Lymphoma Treated with Rituximab Shows Significant Improvement Compared with Watchful-Waiting

Maria A. V. Marzolini, Wendi Qian, Laura Clifton-Hadley,Pip Patrick,June Warden,Lindsey Stevens,Christopher F. E. Pocock,Fiona Miall,David Cunningham, Richard Stephens,Jan Walewski, Amanda Johnston, John F. Seymour,David C. Linch,Kirit M. Ardeshna

BRITISH JOURNAL OF HAEMATOLOGY (2024)

引用0浏览0WOS引用

TRANSCRIPTIONAL NETWORKS ASSOCIATED WITH TREATMENT FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA: DATA FROM THE RATHL TRIAL (CRUK/07/033)

S.H. Lim,C. Burton,S. Barrans,A. Kirkwood,P. Patrick,L. Stevens,L. Clifton‐Hadley,P.W. Johnson,S.M. Thirdborough

Hematological oncologyno. S2 (2019): 293-294

引用0浏览0引用

CAN BASELINE PET‐CT FEATURES PREDICT OUTCOMES IN ADVANCED HODGKIN LYMPHOMA? A PROSPECTIVE EVALUATION OF UK PATIENTS IN THE RATHL TRIAL (CRUK/07/033)

L.C. Pike,A.A. Kirkwood,P. Patrick,J. Radford,C. Burton,L. Stevens,L. Clifton‐Hadley,P.W. Johnson,S.F. Barrington

Hematological Oncologyno. S2 (2017): 37-38

引用0浏览0引用

OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODGKIN LYMPHOMA IN THE RATHL TRIAL (CRUK/07/033)

A. Preston,A. Kirkwood,M. Federico,J. Trotman,A. Fossa,L. Stevens, L. Clifton‐Hadley,P. Patrick,L. Berkahn,F. d'Amore,G. Enblad,S. Luminari,J. Radford,P.W. Johnson

Hematological Oncologyno. S2 (2017): 172-172

引用1浏览0引用

RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033)

J. Trotman,A. Fosså,M. Federico,L. Stevens,A. Kirkwood,L. Clifton-Hadley,P. Patrick,L. Berkahn,F. D'Amore,G. Enblad,S. Luminari,J. Radford,S.F. Barrington,P. Johnson

Hematological Oncology（2017）

引用22浏览0引用

Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation (Ric-Allo) As Front-Line Therapy for Mantle Cell Lymphoma (MCL): Results from the UK Phase II Mini Allo Study (CRUK: C7627/A9080)

D. L. Tucker,K. S. Peggs,G. Cook,N. Russell,A. Hunter,S. Robinson,N. J. Morley,A. Sureda,P. Smith,P. Patrick,N. Braganca,L. Stevens, T. Adedayo,A. A. Kirkwood,S. Rule

BRITISH JOURNAL OF HAEMATOLOGY（2016）

引用0浏览0引用

Reduced Intensity Conditioning transplantation (RIC) as part of first line therapy for Mantle cell lymphoma: results from the Phase II Mini Allo trial (CRUK: C7627/A9080)

K. Peggs,G. Cook,N. Russell,A. Hunter,S. Robinson,N. Morley,A. Sureda,P. Smith,P. Patrick,N. Braganca,L. Stevens, T. Adedayo,A. Kirkwood,S. Rule

BONE MARROW TRANSPLANTATION（2016）

引用0浏览0引用

THE IMPACT OF TREATMENT TYPE AND AGE ON OVARIAN TOXICITY IN THE RATHL STUDY

R. A. Anderson, R. Remedios,A. A. Kirkwood,P. Patrick,L. Stevens,T. Roberts, A. M. Carella,M. Federico,A. Fossa, C. Hatton,N. Kalakonda, D. W. Milligan,P. Mckay,J. Radford,C. Rowntree, F. Scott,P. Smith,P. W. M. Johnson

HAEMATOLOGICA（2016）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn